IGC PHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $801.5K | $13.5M | $1.5M |
| FY2017 | $452.1K | $7.4M | $538.0K |
| FY2018 | — | $8.1M | $1.7M |
| FY2019 | — | $33.6M | $25.6M |
| FY2020 | $0 | $26.5M | $7.3M |
| FY2021 | $276.0K | $32.8M | $14.5M |
| FY2022 | $144.0K | $23.9M | $10.5M |
| FY2023 | $141.0K | $14.9M | $3.2M |
| FY2024 | $137.0K | $7.3M | $1.2M |
| FY2025 | $134.0K | $6.3M | $405.0K |